Cooperation for Primary Care Patients on Sick Leave for CMD: Care Manager and Workplace Intervention - CO-WORK-CARE
Condition(s) studied
Investigational drug(s) / intervention(s)
Workplace convergence dialogue: Work place contact as a convergence dialogue between the employer and employee with the Rehab Coordinator as a guide
Care Manager: Regular contact Care Manager during around 12 weeks
Study summary
This study aims to evaluate whether a convergence dialogue during sick leave, between the employee and the employer, with the Primary Care Centre Rehab Coordinator as discussion leader, leads to reduced sick leave time compared to those individuals who only have contact with a Care Manager during the period of sick leave. The study will be performed as a randomised controlled trial with randomisation at the PCC level where intervention PCCs offers a convergence dialogue meeting with the work place representative during sick leave in addition to Care Manager contact.
Eligibility
Primary outcome measure(s)
- Net and gross sick-leave days — 12 months
number of net and gross sick-leave days during 12 months
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Department of Primary Health Care, Sahlgrenska Academy | Gothenburg | Region Västra Götaland |
More Göteborg University trials in Sweden
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT03250026 on ClinicalTrials.gov ↗ ← All trials in Sweden